BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 8201847)

  • 21. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury.
    Yoshiyama M; Kim S; Yamagishi H; Omura T; Tani T; Yanagi S; Toda I; Teragaki M; Akioka K; Takeuchi K
    Am Heart J; 1994 Jul; 128(1):1-6. PubMed ID: 8017262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
    Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
    Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats.
    Wada T; Sanada T; Ojima M; Kanagawa R; Nishikawa K; Inada Y
    Hypertens Res; 1996 Dec; 19(4):247-54. PubMed ID: 8986455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG; Scheer C; Rupp H
    J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy.
    Mukawa H; Toki Y; Miyazaki Y; Matsui H; Okumura K; Ito T
    Hypertens Res; 2003 Jan; 26(1):89-95. PubMed ID: 12661917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
    J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
    Inada Y; Wada T; Shibouta Y; Ojima M; Sanada T; Ohtsuki K; Itoh K; Kubo K; Kohara Y; Naka T
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1540-7. PubMed ID: 8138966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
    Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
    J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
    Kanagawa R; Wada T; Sanada T; Ojima M; Inada Y
    Jpn J Pharmacol; 1997 Mar; 73(3):185-90. PubMed ID: 9127812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers.
    Delacrétaz E; Nussberger J; Biollaz J; Waeber B; Brunner HR
    Hypertension; 1995 Jan; 25(1):14-21. PubMed ID: 7843746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of angiotensin II receptor antagonism on vascular hypertrophy and aortic impedance in abdominal aortic-banded rat.
    Obayashi M; Yano M; Kohno M; Kobayashi S; Yamamoto T; Ohkusa T; Konishi M; Matsuzaki M
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):381-7. PubMed ID: 10232498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
    Ishiye M; Umemura K; Uematsu T; Nakashima M
    Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
    Peng F; Lin J; Lin L; Tang H
    Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats.
    Kobayashi N; Nishikimi T; Horinaka S; Ishimitsu T; Matsuoka H
    Atherosclerosis; 2001 Jun; 156(2):255-65. PubMed ID: 11395021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
    Kohya T; Yokoshiki H; Tohse N; Kanno M; Nakaya H; Saito H; Kitabatake A
    Circ Res; 1995 May; 76(5):892-9. PubMed ID: 7729007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats.
    Yamagishi H; Kim S; Nishikimi T; Takeuchi K; Takeda T
    J Mol Cell Cardiol; 1993 Nov; 25(11):1369-80. PubMed ID: 8301670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats.
    Ménard J; Campbell DJ; Azizi M; Gonzales MF
    Circulation; 1997 Nov; 96(9):3072-8. PubMed ID: 9386177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats.
    Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Kobayashi T; Shirataki H; Matsuoka H
    Atherosclerosis; 2001 Oct; 158(2):359-68. PubMed ID: 11583714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.